By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today announced two acquisitions totaling $220 million in aggregate to expand its informatics and software offerings and enable customers to access and share enterprise-wide data "for faster, more informed scientific decisions."

The Waltham, Mass.-based firm has signed a definitive agreement to acquire CambridgeSoft in one deal and completed its purchase of ArtusLabs in the other. The CambridgeSoft acquisition is expected to close in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.